BOSTON SCIENTIFIC CORPORATION Restructuring and Related Cost, Cost Incurred to Date
BOSTON SCIENTIFIC CORPORATION (BSX) had Restructuring and Related Cost, Cost Incurred to Date of $318.00 million as of 2019-12-31, per its 10-K filed 2020-02-25.
Discontinued › Notes › Restructuring and Related Activities
us-gaap:RestructuringAndRelatedCostCostIncurredToDate1 · last filed 2020-02-25
- 2019-12-31: Restructuring and Related Cost, Cost Incurred to Date $318.00M.
- 2017-12-31: Restructuring and Related Cost, Cost Incurred to Date $403.00M.
- 2016-12-31: Restructuring and Related Cost, Cost Incurred to Date $308.00M.
- 2016-09-30: Restructuring and Related Cost, Cost Incurred to Date $285.00M.
| Period end | Restructuring and Related Cost, Cost Incurred to Date |
|---|---|
| 2019-12-31 | $318.00M 10-K · filed 2020-02-25 |
| 2017-12-31 | $403.00M 10-K · filed 2018-02-20 |
| 2016-12-31 | $308.00M 10-K · filed 2017-02-23 |
| 2016-09-30 | $285.00M 10-Q · filed 2016-11-03 |
| 2016-06-30 | $268.00M 10-Q · filed 2016-08-03 |
| 2015-12-31 | $515.00M 10-K · filed 2016-02-24 |
| 2015-09-30 | $490.00M 10-Q · filed 2015-11-04 |
| 2015-06-30 | $469.00M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $454.00M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $717.00M 10-K · filed 2015-02-25 |
| 2014-09-30 | $509.00M 10-Q · filed 2014-11-05 |
| 2014-06-30 | $492.00M 10-Q · filed 2014-08-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |